ORCID as entered in ROS
![orcid_icon](/themes/resgate8/images/icons/ORCIDiD_icon24x24.png)
Select Publications
2024, 'Abnormalities of cortical stimulation strength-duration time constant in amyotrophic lateral sclerosis', Clinical Neurophysiology, 164, pp. 161 - 167, http://dx.doi.org/10.1016/j.clinph.2024.05.014
,2024, 'Distinct neuronal circuits mediate cortical hyperexcitability in amyotrophic lateral sclerosis.', Brain, 147, pp. 2344 - 2356, http://dx.doi.org/10.1093/brain/awae049
,2024, 'Novel approaches to assessing upper motor neuron dysfunction in motor neuron disease/amyotrophic lateral sclerosis: IFCN handbook chapter', Clinical Neurophysiology, 163, pp. 68 - 89, http://dx.doi.org/10.1016/j.clinph.2024.04.010
,2024, 'Reduction in short interval intracortical inhibition from the early stage reflects the pathophysiology in amyotrophic lateral sclerosis: A meta-analysis study', European Journal of Neurology, 31, http://dx.doi.org/10.1111/ene.16281
,2024, 'Stroke is not optional for neurologists.', Pract Neurol, http://dx.doi.org/10.1136/pn-2024-004230
,2024, 'Consensus for experimental design in electromyography (CEDE) project: Checklist for reporting and critically appraising studies using EMG (CEDE-Check)', Journal of Electromyography and Kinesiology, 76, http://dx.doi.org/10.1016/j.jelekin.2024.102874
,2024, 'Identifying optimized assessment of nerve damage during chemotherapy.', Journal of Clinical Oncology, 42, pp. 12016 - 12016, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.12016
,2024, 'Characterising vincristine-induced peripheral neuropathy in adults: symptom development and long-term persistent outcomes', Supportive Care in Cancer, 32, http://dx.doi.org/10.1007/s00520-024-08484-5
,2024, 'Nanoplastics and Neurodegeneration in ALS', Brain Sciences, 14, http://dx.doi.org/10.3390/brainsci14050471
,2024, 'Upper and lower limb tremor in Charcot–Marie–Tooth neuropathy type 1A and the implications for standing balance', Journal of Neurology, 271, pp. 1776 - 1786, http://dx.doi.org/10.1007/s00415-023-12124-z
,2024, 'Axonal excitability as an early biomarker of nerve involvement in hereditary transthyretin amyloidosis', Clinical Neurophysiology, 159, pp. 81 - 95, http://dx.doi.org/10.1016/j.clinph.2024.01.006
,2024, 'The glymphatic system and Amyotrophic lateral sclerosis', Progress in Neurobiology, 234, http://dx.doi.org/10.1016/j.pneurobio.2024.102571
,2024, 'Upper and lower limb tremor in inflammatory neuropathies', Clinical Neurophysiology, 158, pp. 69 - 78, http://dx.doi.org/10.1016/j.clinph.2023.12.005
,2024, 'An attentional and working memory theory of hallucination vulnerability in frontotemporal dementia', Brain Communications, 6, http://dx.doi.org/10.1093/braincomms/fcae123
,2024, 'Serum neurofilament light chain in hereditary transthyretin amyloidosis: validation in real-life practice', Amyloid, 31, pp. 95 - 104, http://dx.doi.org/10.1080/13506129.2024.2313218
,2024, 'Short tandem repeat expansions in LRP12 are absent in cohorts of familial and sporadic amyotrophic lateral sclerosis patients of European ancestry', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, http://dx.doi.org/10.1080/21678421.2024.2348636
,2024, 'Consensus for experimental design in electromyography (CEDE) project: Application of EMG to estimate muscle force', Journal of Electromyography and Kinesiology, pp. 102910 - 102910, http://dx.doi.org/10.1016/j.jelekin.2024.102910
,2023, 'Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis', Acta Neuropathologica Communications, 11, http://dx.doi.org/10.1186/s40478-023-01670-2
,2023, 'The importance of patient-centred drug development for amyotrophic lateral sclerosis', Neuropathology and Applied Neurobiology, 49, http://dx.doi.org/10.1111/nan.12944
,2023, 'Utility of split hand index with different motor unit number estimation techniques in ALS', Clinical Neurophysiology, 156, pp. 175 - 182, http://dx.doi.org/10.1016/j.clinph.2023.09.018
,2023, 'Emerging role for sphingolipids in the genetics of amyotrophic lateral sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 95, pp. 101 - 102, http://dx.doi.org/10.1136/jnnp-2023-332719
,2023, 'Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia', Clinical Neurophysiology, 154, pp. 157 - 168, http://dx.doi.org/10.1016/j.clinph.2023.08.002
,2023, 'Imbalance and lower limb tremor in chronic inflammatory demyelinating polyradiculoneuropathy', Journal of the Peripheral Nervous System, 28, pp. 415 - 424, http://dx.doi.org/10.1111/jns.12574
,2023, 'Presymptomatic spinal muscular atrophy: a cautionary approach to the proposed new terminology', Brain, 146, pp. E65 - E66, http://dx.doi.org/10.1093/brain/awad061
,2023, 'Survival in sporadic ALS is associated with lower p62 burden in the spinal cord', Journal of Neuropathology and Experimental Neurology, 82, pp. 769 - 773, http://dx.doi.org/10.1093/jnen/nlad051
,2023, 'Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis', Current Opinion in Neurology, 36, pp. 353 - 359, http://dx.doi.org/10.1097/WCO.0000000000001162
,2023, 'Hyperexcitability, neurodegeneration, and disease progression in amyotrophic lateral sclerosis', Muscle and Nerve, 68, pp. 103 - 105, http://dx.doi.org/10.1002/mus.27843
,2023, 'Treatment with the copper compound CuATSM has no significant effect on motor neuronal pathology in patients with ALS', Neuropathology and Applied Neurobiology, 49, http://dx.doi.org/10.1111/nan.12919
,2023, 'UNC13A in amyotrophic lateral sclerosis: From genetic association to therapeutic target', Journal of Neurology, Neurosurgery and Psychiatry, 94, pp. 649 - 656, http://dx.doi.org/10.1136/jnnp-2022-330504
,2023, 'Clinical diagnostic utility of transcranial magnetic stimulation in neurological disorders. Updated report of an IFCN committee', Clinical Neurophysiology, 150, pp. 131 - 175, http://dx.doi.org/10.1016/j.clinph.2023.03.010
,2023, 'Dependence of cortical neuronal strength-duration properties on TMS pulse shape', Clinical Neurophysiology, 150, pp. 106 - 118, http://dx.doi.org/10.1016/j.clinph.2023.03.012
,2023, 'Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension', eClinicalMedicine, 60, http://dx.doi.org/10.1016/j.eclinm.2023.102036
,2023, 'Strength-duration properties and excitability of motor and sensory axons across different target thresholds', Journal of Neurophysiology, 129, pp. 1434 - 1446, http://dx.doi.org/10.1152/jn.00456.2022
,2023, 'The lower motor neuron homunculus: function matters', Brain, 146, pp. E34 - E35, http://dx.doi.org/10.1093/brain/awad021
,2023, 'Short tandem repeat expansions in sporadic amyotrophic lateral sclerosis and frontotemporal dementia', Science Advances, 9, http://dx.doi.org/10.1126/sciadv.ade2044
,2023, 'Cortical inhibition and facilitation are mediated by distinct physiological processes', Neuroscience Letters, 803, http://dx.doi.org/10.1016/j.neulet.2023.137191
,2023, 'Neurotoxic risks from over-the-counter vitamin supplements', Medical Journal of Australia, 218, pp. 304 - 306, http://dx.doi.org/10.5694/mja2.51851
,2023, 'Chronic inflammatory demyelinating polyradiculoneuropathy-associated tremor: Phenotype and pathogenesis', European Journal of Neurology, 30, pp. 1059 - 1068, http://dx.doi.org/10.1111/ene.15693
,2023, 'Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis', Brain, 146, pp. E17 - E19, http://dx.doi.org/10.1093/brain/awac467
,2023, 'Consensus for experimental design in electromyography (CEDE) project: Single motor unit matrix', Journal of Electromyography and Kinesiology, 68, http://dx.doi.org/10.1016/j.jelekin.2022.102726
,2023, 'Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic review', Journal of Cancer Survivorship, 17, pp. 222 - 236, http://dx.doi.org/10.1007/s11764-021-00988-x
,2023, 'Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important Changes', JNCCN Journal of the National Comprehensive Cancer Network, 21, pp. 125 - 132, http://dx.doi.org/10.6004/jnccn.2022.7074
,2023, 'Apathy in amyotrophic lateral sclerosis: systematic review and meta-analysis of frequency, correlates, and outcomes', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24, pp. 14 - 23, http://dx.doi.org/10.1080/21678421.2022.2053721
,2023, 'Clinical and neurophysiological biomarkers of disease progression in amyotrophic lateral sclerosis', Muscle and Nerve, 67, pp. 17 - 24, http://dx.doi.org/10.1002/mus.27736
,2023, 'Diagnostic utility of transcranial magnetic stimulation for neurodegenerative disease: a critical review', Dementia e Neuropsychologia, 17, http://dx.doi.org/10.1590/1980-5764-DN-2023-0048
,2023, 'Distinct hypothalamic involvement in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum', NeuroImage: Clinical, 37, http://dx.doi.org/10.1016/j.nicl.2022.103281
,2023, 'Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis', Brain Communications, 5, http://dx.doi.org/10.1093/braincomms/fcac340
,2023, 'Nanocrystalline gold (CNM-Au8): a novel bioenergetic treatment for ALS', Expert Opinion on Investigational Drugs, 32, pp. 783 - 785, http://dx.doi.org/10.1080/13543784.2023.2263368
,2023, 'N°51 – Phenotype and pathogenesis of upper limb tremor in CIDP', Clinical Neurophysiology, 150, pp. e88 - e88, http://dx.doi.org/10.1016/j.clinph.2023.03.060
,2022, 'Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1', Genome Medicine, 14, http://dx.doi.org/10.1186/s13073-021-01006-6
,